☆ 4.6 Article

COVID-19-Associated Pulmonary Fungal Infection among Pediatric Cancer Patients, a Single Center Experience

JOURNAL OF FUNGI (2022)

Related references

Note: Only part of the references are listed.

Review Pediatrics

SARS-CoV-2 in pediatric cancer: a systematic review

Sandy Schlage et al.

Summary: A comprehensive overview of pediatric cancer patients with SARS-CoV-2 infections found that most patients have mild symptoms, but the mortality rate is higher compared to hospitalized children without comorbidities. Some cases showed no severe COVID-19 complications despite continuing chemotherapy.

EUROPEAN JOURNAL OF PEDIATRICS (2022)

Add to Collection

Article Immunology

Coronavirus Disease 2019-Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients

Nitipong Permpalung et al.

Summary: COVID-19-associated pulmonary aspergillosis (CAPA) is a serious condition in critically ill patients. A retrospective cohort study was conducted on mechanically ventilated adult patients with COVID-19, and it was found that CAPA is associated with underlying pulmonary vascular and liver diseases. Patients with CAPA have worse outcomes, requiring longer time for improvement and longer hospital stays.

CLINICAL INFECTIOUS DISEASES (2022)

Add to Collection

Review Infectious Diseases

The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries

Martin Hoenigl et al.

Summary: Reports of COVID-19-associated mucormycosis, particularly among patients with uncontrolled diabetes, have been increasing since early 2021. Most patients with COVID-19-associated mucormycosis have uncontrolled diabetes and receive systemic corticosteroid treatment, and rhino-orbital cerebral mucormycosis is the most common disease. COVID-19-associated mucormycosis is associated with high mortality and a significant proportion of survivors experience life-changing morbidities.

LANCET MICROBE (2022)

Add to Collection

Review Oncology

Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9)

Simone Cesaro et al.

Summary: SARS-CoV-2 infection can lead to severe outcomes in immunocompromised hematological patients, with high mortality rates observed. Treatment strategies focus on controlling viral replication and inflammation. However, the effectiveness and benefits of preventive and therapeutic measures in hematological patients require further investigation.

LEUKEMIA (2022)

Add to Collection

Article Immunology

Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study

Michele Bartoletti et al.

Summary: The study showed a high incidence of CAPA among critically ill COVID-19 patients, and its occurrence seems to alter the natural course of the disease.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Immunology

A National Strategy to Diagnose Coronavirus Disease 2019-Associated Invasive Fungal Disease in the Intensive Care Unit

P. Lewis White et al.

Summary: Invasive fungal disease is common in critically ill COVID-19 patients, with 26.7% incidence rate including 14.1% aspergillosis and 12.6% yeast infections. Mortality rates are reduced with antifungal therapy, while corticosteroid use and history of chronic respiratory disease increase the likelihood of aspergillosis. Strategic diagnostic screening and antifungal prophylaxis may enhance the management of COVID-19 patients.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Review Immunology

COVID-19 associated with pulmonary aspergillosis: A literature review

Chih-Cheng Lai et al.

Summary: Co-infections of Aspergillus spp. in patients with COVID-19, especially in severe/critical cases, have been reported with incidence ranging from 19.6% to 33.3%. Acute respiratory distress syndrome and high mortality rates are common complications, while early diagnosis through fungus culture and galactomannan testing is crucial for appropriate management. Vigilance and aggressive microbiological studies are recommended for severe/critical COVID-19 patients to detect pulmonary aspergillosis promptly.

JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2021)

Add to Collection

Article Pediatrics

Assessment of 135 794 Pediatric Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 Across the United States

L. Charles Bailey et al.

Summary: This cohort study of US pediatric patients found low rates of SARS-CoV-2 infection, with mild clinical manifestations. Infection was associated with Black, Hispanic, and Asian race/ethnicity, adolescence and young adulthood, as well as non-respiratory chronic medical conditions. The study suggests higher concern may be warranted for patients with complex medical conditions or minority race/ethnicity.

JAMA PEDIATRICS (2021)

Add to Collection

Article Oncology

SARS-CoV-2 in Childhood Cancer in 2020: A Disease of Disparities

Emily E. Johnston et al.

Summary: The study investigated 917 children aged 21 and under who were receiving cancer therapy and infected with SARS-CoV-2, with a higher proportion of Hispanics and publicly insured patients represented in the cohort. Most patients were symptomatic, with 31.2% requiring hospitalization, 10.9% needing respiratory support, 9.2% admitted to the ICU, and 1.6% died due to SARS-CoV-2.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Add to Collection

Article Immunology

Coronavirus Disease 2019-Associated Invasive Fungal Infection

John W. Baddley et al.

Summary: COVID-19 can lead to secondary invasive fungal infections, particularly in cases of severe lung damage or immunological deficits. Various fungal infections can occur, presenting challenges in diagnosis and management.

OPEN FORUM INFECTIOUS DISEASES (2021)

Add to Collection

Review Public, Environmental & Occupational Health

Systematic Review Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review

W. H. Chong et al.

Summary: CAPA is defined as invasive pulmonary aspergillosis occurring in COVID-19 patients, with a high mortality rate of 48.4%. The diagnosis is limited by lack of standardized criteria, necessitating further research to determine the optimal diagnostic approach.

JOURNAL OF HOSPITAL INFECTION (2021)

Add to Collection

Article Microbiology

COVID-19-Associated Pulmonary Aspergillosis in Patients with Acute Leukemia: A Single-Center Study

Jovan Rajic et al.

Summary: This study aimed to evaluate the occurrence of invasive pulmonary aspergillosis (IPA) in COVID-19 patients, finding that approximately 22% of acute leukemia patients may have COVID-19-associated pulmonary aspergillosis (CAPA). Detection of serum GM and IgM anti-Aspergillus antibodies is critical for diagnosis, and early diagnosis and treatment are essential for improving survival rates.

JOURNAL OF FUNGI (2021)

Add to Collection

Review Microbiology

When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis

Teny M. John et al.

Summary: Poorly controlled diabetes and severe COVID-19 are the main risk factors for COVID-19-associated mucormycosis, which typically presents with rhino-orbital or rhino-cerebral syndromes and nearly all infections are confirmed, highlighting the need for heightened awareness among treating physicians.

JOURNAL OF FUNGI (2021)

Add to Collection

Article Oncology

Management and Outcome of Coronavirus Disease 2019 (COVID-19) in Pediatric Cancer Patients: A Single Centre Experience from a Developing Country

Mahmoud Hammad et al.

Summary: The study investigated the impact of COVID-19 on 76 pediatric oncology patients and found that most patients had a good prognosis, with a 60-day overall survival rate of 86.8%. The potential benefits of remdesivir in pediatric oncology patients with COVID-19 need further study.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2021)

Add to Collection

Article Dermatology

ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries

Shivaprakash M. Rudramurthy et al.

Summary: Globally, the incidence of COVID-19-associated mucormycosis (CAM) is rising, with a significant surge in India. The need to address misconceptions in managing and treating this infection is crucial, with a focus on early suspicion, diagnosis confirmation, glycemic control, surgical debridement, and antifungal therapy. Limited availability of amphotericin B formulations during the epidemic has led to discussions on alternative antifungal therapies.

MYCOSES (2021)

Add to Collection

Article Immunology

COVID-19-Associated Pulmonary Aspergillosis, March-August 2020

Jon Salmanton-Garcia et al.

Summary: This study found that most patients with coronavirus disease-associated pulmonary aspergillosis (CAPA) are diagnosed shortly after admission, with the majority being treated in the ICU. Azole-resistant strains of Aspergillus fumigatus were common in patients, and voriconazole was the main treatment choice. The overall mortality rate was approximately 52.2%, with about one third of deaths attributed to CAPA.

EMERGING INFECTIOUS DISEASES (2021)

Add to Collection

Review Microbiology

Aspergillus fumigatus and Aspergillosis in 2019

Jean-Paul Latge et al.

CLINICAL MICROBIOLOGY REVIEWS (2020)

Add to Collection

Editorial Material Immunology

High Rates of Influenza-Associated Invasive Pulmonary Aspergillosis May Not Be Universal: A Retrospective Cohort Study from Alberta, Canada

Ilan S. Schwartz et al.

CLINICAL INFECTIOUS DISEASES (2020)

Add to Collection

Letter Critical Care Medicine

COVID-19-associated Pulmonary Aspergillosis

Andreas L. E. van Arkel et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

Add to Collection

Review Radiology, Nuclear Medicine & Medical Imaging

Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review

Zheng Ye et al.

EUROPEAN RADIOLOGY (2020)

Add to Collection

Editorial Material Oncology

Early impact of the COVID-19 pandemic on paediatric cancer care in Latin America Comment

Liliana Vasquez et al.

LANCET ONCOLOGY (2020)

Add to Collection

Letter Critical Care Medicine

Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19

Alexandre Alanio et al.

LANCET RESPIRATORY MEDICINE (2020)

Add to Collection

Article Dermatology

COVID-19 associated pulmonary aspergillosis

Philipp Koehler et al.

MYCOSES (2020)

Add to Collection

Review Microbiology

COVID-19 Associated Pulmonary Aspergillosis (CAPA)-From Immunology to Treatment

Amir Arastehfar et al.

JOURNAL OF FUNGI (2020)

Add to Collection

Review Hematology

Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients

Abi Vijenthira et al.

BLOOD (2020)

Add to Collection

Review Infectious Diseases

Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance

Philipp Koehler et al.

LANCET INFECTIOUS DISEASES (2020)

Add to Collection

Review Infectious Diseases

Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

Oliver A. Cornely et al.

LANCET INFECTIOUS DISEASES (2019)

Add to Collection

Article Immunology

Breakthrough Invasive Mold Infections in the Hematology Patient: Current Concepts and Future Directions

Michail S. Lionakis et al.

CLINICAL INFECTIOUS DISEASES (2018)

Add to Collection

Article Critical Care Medicine

Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study

Alexander F. A. D. Schauwvlieghe et al.

LANCET RESPIRATORY MEDICINE (2018)

Add to Collection

Editorial Material Immunology

Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses study group and European Organization for Research and Treatment of Cancer consensus criteria

Brahm H. Segal et al.

CLINICAL INFECTIOUS DISEASES (2008)

Add to Collection

© Peeref 2019-2024. All rights reserved.